Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Background The benefit of low‐density lipoprotein cholesterol (LDL‐C) levels in chronic kidney disease populations remains unclear. This study evaluated the cardiovascular and renal outcomes in patients with stage 3 chronic kidney disease with different LDL‐C levels during statin treatment. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Chieh‐Li Yen, Pei‐Chun Fan, Cheng‐Chia Lee, Jia‐Jin Chen, George Kuo, Yi‐Ran Tu, Pao‐Hsien Chu, Hsiang‐Hao Hsu, Ya‐Chung Tian, Chih‐Hsiang Chang
Formato: Artículo
Lenguaje:English
Publicado: Wiley 2022-10-01
Colección:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Materias:
cardiovascular disease
chronic kidney disease
low‐density lipoprotein cholesterol
statin
stroke
Acceso en línea:https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Ejemplares similares